BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35361764)

  • 1. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling.
    Liu M; Li H; Zhang H; Zhou H; Jiao T; Feng M; Na F; Sun M; Zhao M; Xue L; Xu L
    Cell Death Dis; 2022 Mar; 13(3):287. PubMed ID: 35361764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHOJ Induces Epithelial-to-Mesenchymal Transition by IL-6/STAT3 to Promote Invasion and Metastasis in Gastric Cancer.
    Ma Z; Sun Q; Zhang C; Zheng Q; Liu Y; Xu H; He Y; Yao C; Chen J; Xia H
    Int J Biol Sci; 2023; 19(14):4411-4426. PubMed ID: 37781036
    [No Abstract]   [Full Text] [Related]  

  • 5. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
    Liang W; Xia B; He C; Zhai G; Li M; Zhou J
    Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.
    Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
    Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
    Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
    Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
    Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
    Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.
    Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y
    J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
    Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
    Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
    Zhou J; Wu A; Yu X; Zhu J; Dai H
    Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis.
    Chang YC; Su CY; Chen MH; Chen WS; Chen CL; Hsiao M
    Mol Cancer; 2017 Aug; 16(1):135. PubMed ID: 28784136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
    Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
    Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
    Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
    Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
    Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Ma DH; Li BS; Liu JJ; Xiao YF; Yong X; Wang SM; Wu YY; Zhu HB; Wang DX; Yang SM
    Cancer Lett; 2017 Nov; 408():23-32. PubMed ID: 28842285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
    Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
    Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.